Skip to main content
Caplight Logo









RepeatMD

RepeatMD

Private
Houston, TexasHealthcare & Life Scienceshttps://repeatmd.com/

Last Round

Debt

Nov 27, 2023

Total Funding Raised

$11.2M

Company Overview

RepeatMD is a healthcare technology company that provides a patient engagement and revenue automation platform for aesthetic and wellness practices.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, Digital Payments, Marketing

Business Model

B2B2C

Customer Profile

Subscription SaaS, Payment Processing Fee

AI Layer

Application

Keywords

patient engagementvertical SaaSmed spa softwareloyalty program softwarepatient retentionmedical practice managementpayment processingmembership managementaesthetic clinic softwaremedtechpatient appautomated marketingfintech for healthcarepractice growth platformB2B2C

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RepeatMD Comparables

Compare RepeatMD with similar companies based on industry and business-model similarity.

RepeatMD comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aesthetic Record
82%
MedShift
78%
Growth99
78%

RepeatMD Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtNov 27, 2023
SeedDec 1, 2022

Key People

Founding team and executive leadership

JT Bruch

Chief Technology Officer

Executive Team

RepeatMD Investors

Notable investors and investment history

RepeatMD investors
InvestorRounds
Full In PartnersDebt
PROOFDebt
Silicon Valley BankDebt
Mercury FundDebt, Seed
Centana Growth PartnersDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 23, 2025

    Launched V3 AI-powered Medcommerce platform for aesthetic and wellness practices.

  • Mar 18, 2025

    Integrated patient engagement tools with Aesthetic Record's system.

RepeatMD Filings

Explore SEC and related filing metadata, where available.

RepeatMD filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RepeatMD's valuation, stock price, and market status.

Is RepeatMD a public or private company?

RepeatMD is a private company.

What is the current stock price of RepeatMD?

RepeatMD is a private company with no public stock price. No recent secondary market data is available.

How much is RepeatMD worth (valuation)?

Valuation information for RepeatMD is not publicly available.

Can I buy RepeatMD stock?

RepeatMD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RepeatMD's last funding round?

RepeatMD's most recent funding round was Series A on November 27, 2023.

Who are the main investors in RepeatMD?

Key investors in RepeatMD include Full In Partners, Mercury Fund, Centana Growth Partners.

Will RepeatMD IPO soon?

No public IPO plans have been announced for RepeatMD.

How can I track RepeatMD secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RepeatMD's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Employee Range80
Year Founded2021
Last FundingNov 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?